Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04443010
Title Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma (GLIOSUN)
Acronym GLIOSUN
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Philogen S.p.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.